Cosmetic Botox & FillersBotox, Xeomin & Dermal Fillers Scottsdale, AZ

Softening starts in 3–7 days and peaks around two weeks. Most people return every 3–4 months. Coming back as the effect fades — not after it is gone — often needs less product over time.

Botox relaxes the muscles that etch lines. Hyaluronic acid fillers restore volume. Many faces need both. Combined treatment is standard when muscle activity and volume loss are both present.

A nerve ending releases acetylcholine to tell a muscle to contract. Type A toxin clips SNAP-25, a SNARE protein, so that messenger cannot leave the nerve. The muscle is chemically denervated and the line softens. It does not fill a crease. Softening starts in days, peaks around two weeks, and fades as the nerve sprouts and SNAP-25 regenerates.

Same 150 kDa core and SNAP-25 clip, not the same vial. Botox Cosmetic and Jeuveau are 900 kDa complexes. Xeomin is naked 150 kDa toxin. Dysport uses a different potency assay — typical conversion around 2.5–3 to 1 — and tends to spread farther. Daxxify uses a peptide stabilizer; SAKURA held a none-or-mild frown for a median of 24 weeks. Letybo is a newer type A option in the same class. Units do not convert 1:1.

HA is a cross-linked sugar gel that occupies space and holds water — physical volumization, not a nerve block. Higher G-prime products lift a cheek or jaw; softer gels sit in a lip or a fine line. Hyaluronidase reverses HA. Sculptra and Radiesse are biostimulatory — hyaluronidase will not undo them.

Not if the dose modulates instead of paralyzing. Over-weakening the forehead is a common reason a brow looks flat. We map the unit so you can still raise your brows.

No. Cosmetic Botox treats voluntary expression lines. Therapeutic Botox treats miswiring after facial palsy. If your eye closes when you smile, that is the other page.

HA fillers are reversible. The serious risk is intravascular injection, which can injure skin or, rarely, vision. The nose, forehead, glabella, and temple account for most reported vision-loss cases. We keep hyaluronidase ready and treat visual change as an emergency — established vision loss is rarely reversed.

Neuromodulators: Botox Cosmetic, Xeomin, Dysport, Daxxify, Jeuveau, and Letybo. Hyaluronic acid: Juvéderm Ultra, Ultra Plus, Voluma, Volbella, Vollure, Volux, and Skinvive; Restylane, Lyft, Silk, Kysse, Refyne, Contour, Eyelight, and Skinboosters; RHA 2, 3, 4, and Redensity; Belotero Balance; Revanesse Versa and Lips. The unit picks the product.

A long upper lip, a descended midface, a heavy neck, or true eyelid bags will not be fixed by more product. Those belong with a lip lift, deep-plane facelift, or blepharoplasty.

Longer than most people expect, but as a range rather than a date. Imaging-based reviews report substantial persistence of hyaluronic acid at one year and, for many products, still measurable volume at two years, varying with cross-linking, the site injected, and how mobile that tissue is. Reported satisfaction tends to track measured volume, so a filler can still be present while looking less full than on day one.

A blunt-tipped cannula is less likely to pierce a vessel wall, but it does not remove the risk. In one series of vascular complications, most nasal-region vision-loss cases had in fact been injected with a cannula. Depth, volume, injection pressure and rate, the region treated, and operator experience all matter, which is why the nose, glabella, forehead, and temple are treated as high-risk regardless of instrument.

Not necessarily, and this is a safety question rather than a value question. Counterfeit or mishandled botulinum toxin has been linked to systemic botulism. Treatment should take place in a clinical setting using authentic, traceable product, with someone who can recognize and manage a complication, including having hyaluronidase available when hyaluronic acid filler is used.